M. Patricia Beckmann
Life Science Washington
Patricia's career spans biomedical research, operations, law and venture capital. In 2017 she joined Life Science Washington, the state's life sciences trade association. As VP of Commercialization, Patricia oversees the organization's efforts to assist life science researchers, entrepreneurs, and companies in bridging the gap between discovery and commercialization through free consulting to member companies, educational and company showcase events, and the creation of resources pertinent to the issues faced by technology commercialization in Washington state.
Before her current role, Patricia has been Managing Director of BioStrategy, LLC where she has advised early-stage biotechnology, medical device, digital health, and agricultural-related companies.
She was the Chief Technology Development Officer for CDRD Ventures (CVI) in Vancouver, BC. CVI is the for-profit commercialization vehicle of the not-for-profit Centre for Drug Research and Development (CDRD), Canada's national drug development and commercialization centre. Patricia was also President and Executive Director of the non-profit Oregon Translational Research and Development Institute (OTRADI), where she established a small fund and incubator model for Oregon start-ups.
Patricia spent several years in venture capital, first as part of the bioscience investment team at Vulcan Capital, and later as a Kauffman Fellow at Accelerator Corp.
Beofre her investing career, Patricia spent most of her research career at Immunex (co-inventor of Enbrel, Mobista and Nuvance) as well as several years in the Immunex and Amgen Law Departments performing technology assessment for licensing, intellectual property and litigation support.
Education, Personal, and Fellowship
Patricia earned her BA in biology, chemistry and art from The Evergreen State College and her PhD in biochemistry and pharmacology from the University of Arizona, College of Medicine. She is a two-time Fulbright Scholar pursuing studies in Sweden and India and was a Visiting Scientist at the National Institutes of Health, National Cancer Institute.
Patricia was a member of Class 12. She served her fellowship under mentors Bill Newman at Northwest Technology Ventures and Carl Weissman at Accelerator Corporation.